Javier Martín-López

7PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyVision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 10, 2026
Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.

Belén Sierra-Rodero, Ángeles Gil-González, Marta Molina-Alejandre

|Jan 15, 2026
Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non-Small Cell Lung Cancer.

Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal

|Oct 20, 2024
Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer.

Marta Molina-Alejandre, Francisco Perea, Virginia Calvo

|Jun 28, 2023
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.

Mariano Provencio, Ernest Nadal, José L González-Larriba

|May 16, 2022
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).

Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal

|Dec 24, 2021
The Role of the Stromal Extracellular Matrix in the Development of Pterygium Pathology: An Update.

Javier Martín-López, Consuelo Pérez-Rico, Selma Benito-Martínez

Pageof 2